Perspective Therapeutics (CATX) Raw Materials (2011 - 2023)
Perspective Therapeutics (CATX) reported Raw Materials of $764000.0 for Q3 2023, down 16.23% on a YoY basis from $912000.0 in Q3 2022, and down 2.18% sequentially from $781000.0 in Q2 2023.
Perspective Therapeutics (CATX) Raw Materials (2011 - 2023) Analysis & Trends
Perspective Therapeutics (CATX) has 11 years of Raw Materials data on file, last reported at $764000.0 in Q3 2023.
- For the quarter ending Q3 2023, Raw Materials fell 16.23% year-over-year to $764000.0; the trailing twelve-month figure through Sep 2023 stood at $764000.0 (down 16.23% YoY), and the FY2022 full-year result was $752000.0, changed N/A from the prior year.
- Raw Materials retreated to $764000.0 in Q3 2023, from $781000.0 in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $912000.0 in Q3 2022 to a low of $330000.0 in Q3 2019.
- A 5-year average of $598105.3 and a median of $645000.0 in 2021 frame the typical range for Raw Materials.
- Across the five-year window, Raw Materials jumped 98.69% in 2021 and slipped 16.23% in 2023, its largest moves.
- Tracing CATX's Raw Materials over 5 years: stood at $372000.0 in 2019, then gained by 20.43% to $448000.0 in 2020, then soared by 67.63% to $751000.0 in 2021, then climbed by 0.13% to $752000.0 in 2022, then climbed by 1.6% to $764000.0 in 2023.
- Business Quant data shows CATX's Raw Materials at $764000.0 in Q3 2023, $781000.0 in Q2 2023, and $777000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn |
| 10 | Perspective Therapeutics | 303.04 Mn | 303.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 764,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 752,000.00 |
| Sep 30, 2022 | 912,000.00 |
| Jun 30, 2022 | 911,000.00 |
| Mar 31, 2022 | 789,000.00 |
| Dec 31, 2021 | 751,000.00 |
| Sep 30, 2021 | 757,000.00 |
| Jun 30, 2021 | 645,000.00 |
| Mar 31, 2021 | 508,000.00 |
| Dec 31, 2020 | 448,000.00 |
| Sep 30, 2020 | 381,000.00 |
| Jun 30, 2020 | 401,000.00 |
| Mar 31, 2020 | 369,000.00 |
| Dec 31, 2019 | 372,000.00 |
| Sep 30, 2019 | 330,000.00 |
| Jun 30, 2019 | 333,000.00 |
| Mar 31, 2019 | 383,000.00 |
| Dec 31, 2018 | 379,000.00 |